Author(s):
Deby Kusumaningrum, Ni Made Mertaniasih, Soedarsono
Email(s):
ni-made-m@fk.unair.ac.id
DOI:
10.52711/0974-360X.2023.00954 
Address:
Deby Kusumaningrum1,2,4,5, Ni Made Mertaniasih2,4,5, Soedarsono3,4,5
1Doctoral Degree Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
2Department of Clinical Microbiology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
3Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
4Tuberculosis Study Group, Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia.
5Dr Soetomo General Hospital, Surabaya, Indonesia.
*Corresponding Author
Published In:
Volume - 16,
Issue - 12,
Year - 2023
ABSTRACT:
This study identified non-tuberculous mycobacteria (NTM) isolates from the clinical respiratory specimen of patients suspected of chronic tuberculosis at a tertiary referral hospital in Indonesia. In this study, 20 clinical non-tuberculous mycobacteria (NTM) isolates were obtained from respiratory samples examined in the tuberculosis section of the Clinical Microbiology laboratory at Dr Soetomo General Hospital. The isolates were identified using TB Ag MPT 64 (SD Bioline) and targeting 16S rRNA genes sequence for analysis at the species level. Data on clinical features were collected and chest radiographs were evaluated. The highest bacterium found in the isolates was Mycobacterium kansasii (12 strains, 60%.), followed by Mycobacterium gordonae (2 strains, 5%), Mycobacterium parascofulaceum (2 strains, 5%), Mycobacterium avium (1 strain, 2.5%), Mycobacterium simiae (1 strain, 2.5%). Mycobacterium abcessus (1 strain, 2.5%), and Mycobacterium paraterrae (1 strain, 2.5%). Males dominated patients with Mycobacterium kansasii. Clinical symptoms include cough, dyspneu, hemoptysis, chest pain, and sweats. Half of the patients had a history of previous tuberculosis and other comorbid diabetes mellitus. Non-tuberculous mycobacteria (NTM) species identified were dominated by Mycobacterium kansasii. The predominance of non-tuberculous mycobacteria (NTM) species from clinical respiratory can be a reference to determine prudent treatment for patients in high-burden TB countries.
Cite this article:
Deby Kusumaningrum, Ni Made Mertaniasih, Soedarsono. Non-Tuberculous Mycobacteria Infections based on 16S rRNA detections in patients with Suspected Chronic Tuberculosis at a Tertiary Referral Hospital in Indonesia. Research Journal of Pharmacy and Technology.2023; 16(12):5889-5. doi: 10.52711/0974-360X.2023.00954
Cite(Electronic):
Deby Kusumaningrum, Ni Made Mertaniasih, Soedarsono. Non-Tuberculous Mycobacteria Infections based on 16S rRNA detections in patients with Suspected Chronic Tuberculosis at a Tertiary Referral Hospital in Indonesia. Research Journal of Pharmacy and Technology.2023; 16(12):5889-5. doi: 10.52711/0974-360X.2023.00954 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-12-55
REFERENCES:
1. Costa ARF da, Iii JOF, Lopes ML, et al. Occurrence of Nontuberculous Mycobacterial Pulmonary Infection in an Endemic Area of Tuberculosis. PLoS Negl Trop Dis. 2013; 7:e2340.doi.org/10.1371/journal.pntd.0002340
2. Ray S. QSAR Modeling of Antimycobacterial Activities of N-Benzylsalicylamides and N-Benzylsalicylthioamides Derivatives against Mycobacterium kansasii CNCTC My (235/80) Using Topological Parameter. Res J Pharm Technol. 2011; 4:1904–1909.
3. Jabe AS, Manhi K, Alfayyadh I, Hamim SS. Prevalence of Tuberculosis from 2010-2015 in Nasiriyah City/Iraq. Res J Pharm Technol. 2019; 12:2275–2278.doi.org/10.5958/0974-360X.2019.00379.2
4. Griffith DE, Aksamit TR. Nontuberculous Mycobacterial Disease Therapy: Take It to the Limit One More Time. Dis Chest. 2016; 150:1177–1178.doi.org/10.1016/j.chest.2016.07.015
5. Ratnatunga CN, Lutzky VP, Kupz A, et al. The Rise of Non-Tuberculosis Mycobacterial Lung Disease. Front Immunol. 2020; 11
6. Diel R, Lipman M, Hoefsloot W. High mortality in patients with Mycobacterium avium complex lung disease: a systematic review. BMC Infect Dis. 2018; 18:206.doi.org/10.1186/s12879-018-3113-x
7. Lim AYH, Chotirmall SH, Fok ETK, et al. Profiling non-tuberculous mycobacteria in an Asian setting: characteristics and clinical outcomes of hospitalized patients in Singapore. BMC Pulm Med. 2018; 18:85.doi.org/10.1186/s12890-018-0637-1
8. Saptawati L, Kusumo H, Suryawati B. Prevalence of Non-tuberculous Mycobacteria (NTM) in Surakarta, Indonesia: Higher Than Expected. KnE Life Sci. 2019; 4:132.doi.org/10.18502/kls.v4i12.4166
9. Mertaniasih NM, Kusumaningrum D, Koendhori EB, Soedarsono, Kusmiati T, Dewi DNSS. Nontuberculous mycobacterial species and Mycobacterium tuberculosis complex coinfection in patients with pulmonary tuberculosis in Dr. Soetomo Hospital, Surabaya, Indonesia. Int J Mycobacteriology. 2017; 6:9–13.doi.org/10.4103/2212-5531.201894
10. Kumar L, Rajan, Sharma V. Tuberculosis: A Brief Overview. Asian J Pharm Res. 2012; 2:59–62.
11. Budiarti R, Ediono, Mertaniasih NM, Soedarsono. Adenosine Deaminase Detection in Serum of Pulmonary Tuberculosis and Extra Pulmonary Tuberculosis patients at Dr. Ramelan Hospital Surabaya. Res J Pharm Technol. 2022; 15:2987–2991.doi.org/10.52711/0974-360X.2022.00498
12. Iren Z. Bacteriology and Atypical Mycobacteria. Turkish Survey at Yozgat. Rev Med Moyen Orient. 1965; 22:95–98.
13. Prabha Grace S. A Personal Experience with a Tuberculosis patient: A Case Report. Int J Adv Nurs Stud. 2018; 6:290–292.
14. J.Prassanna, Anbarasi LJ, Rukmani.P, Jackson.J C, B.Rajesh, R.Manikandan. CNN based Framework for intelligent Diagnosis of Tuberculosis using Chest Radiographs. Res J Pharm Technol. 2022; 15:4529–4532.doi.org/10.52711/0974-360X.2022.00760
15. Kapadiya MN. Tuberculosis Case Study. Int J Adv Nurs Manag. 2021; 9:160–161.doi.org/10.5958/2454-2652.2021.00036.6
16. Satheesh KG, Noorjahan N, Reddy GS, Mujahid SK, Ashwini T. Extraction, Phytochemical Studies and In-Vitro Screening of the Leaves and Flowers of Crossandra infundibuliformis against Mycobacterium tuberculosis - ProQuest. Asian J Res Pharm Sci. 2018; 8
17. Feng Z, Bai X, Wang T, et al. Differential Responses by Human Macrophages to Infection With Mycobacterium tuberculosis and Non-tuberculous Mycobacteria. Front Microbiol. 2020; 11
18. Kwon Y-S, Koh W-J. Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease. J Korean Med Sci. 2016; 31:649–659.doi.org/10.3346/jkms.2016.31.5.649
19. Noor-Hashimah A, Naing NN, Aminuddin CW, et al. Health Service Delays in Diagnosis and Treatment among Tuberculosis Patients in Kelantan, Malaysia. Res J Pharm Technol. 2018; 11:3711–3717.doi.org/10.5958/0974-360X.2018.00681.9
20. Kristina SA, Andayani TM, Wulandari GP. A Systematic Review of the Direct and Indirect Costs among Tuberculosis Patients. Res J Pharm Technol. 2020; 13:456–460.doi.org/10.5958/0974-360X.2020.00089.X
21. Patil N, Patil MrK, Patil DrS. Analysis Nucleic Acid Analytical Techniques -Current era of Development Perspectives in Diagnosis Field. Asian J Pharm Anal. 2022; 12:271–280.doi.org/10.52711/2231-5675.2022.00045
22. Chin’ombe N, Muzividzi B, Munemo E, Nziramasanga P. Molecular Identification of Nontuberculous Mycobacteria in Humans in Zimbabwe Using 16S Ribosequencing. Open Microbiol. J 2016; 10:113–123.doi.org/10.2174/1874285801610010113
23. Nawan, Handayani S. Molecular identification of Streptomyces sp. isolated from peat land of Palangka Raya, Kalimantan Tengah using 16S rRNA gene sequences analysis. Res J Pharm Technol. 2021; 14:6639–6644.doi.org/10.52711/0974-360X.2021.01147
24. Falih HY, Ali AH, Fadhel ZA. Study of infection levels of Mycobacterium Tuberculosis in a city of Nasiriyah – Iraq. Res J Pharm Technol. 2022; 15:4230–4234.doi.org/10.52711/0974-360X.2022.00711
25. Abe Y, Fukushima K, Hosono Y, et al. Host Immune Response and Novel Diagnostic Approach to NTM Infections. Int J Mol Sci. 2020; 21:4351.doi.org/10.3390/ijms21124351
26. Noviyani A, Nopsopon T, Pongpirul K. Variation of tuberculosis prevalence across diagnostic approaches and geographical areas of Indonesia. PLOS ONE 2021; 16:e0258809.doi.org/10.1371/journal.pone.0258809
27. Aliyu G, El-Kamary SS, Abimiku A, et al. Prevalence of Non-Tuberculous Mycobacterial Infections among Tuberculosis Suspects in Nigeria. PLOS ONE. 2013; 8:e63170.doi.org/10.1371/journal.pone.0063170
28. Pereira AC, Ramos B, Reis AC, Cunha MV. Non-Tuberculous Mycobacteria: Molecular and Physiological Bases of Virulence and Adaptation to Ecological Niches. Microorganisms. 2020; 8:E1380.doi.org/10.3390/microorganisms8091380
29. Falodun O, Fagade O, Cadmus S. Prevalence of Nontuberculous Mycobacteria Infections in Patients Diagnosed with Pulmonary Tuberculosis in Ibadan. Int J Trop Dis Health 2016; 18:1–8.doi.org/10.9734/IJTDH/2016/28058
30. Wani SR, Wattal C, Raveendran R. Epidemiology and risk factors associated with NTM pulmonary and extrapulmonary infections in a high tuberculosis endemic Region. Indian J Med Microbiol. 2020; 38:169–175.doi.org/10.4103/ijmm.IJMM_20_274
31. Griffith DE, Marras TK. Nontuberculous Mycobacterial Disease Epidemiology: You Can See the Stars and Still Not See the Light. Clin Infect Dis Off Publ Infect Dis Soc Am. 2021; 73:e327–e329.doi.org/10.1093/cid/ciaa1096
32. Chin KL, Sarmiento ME, Alvarez-Cabrera N, Norazmi MN, Acosta A. Pulmonary non-tuberculous mycobacterial infections: current state and future management. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2020; 39:799–826.doi.org/10.1007/s10096-019-03771-0
33. Kim S-Y, Han SA, Kim DH, Koh W-J. Nontuberculous mycobacterial lung disease: ecology, microbiology, pathogenesis, and antibiotic resistance mechanisms. Precis Future Med. 2017; 1:99–114.doi.org/10.23838/pfm.2017.00135
34. Matveychuk A, Fuks L, Priess R, Hahim I, Shitrit D. Clinical and radiological features of Mycobacterium kansasii and other NTM infections. Respir Med. 2012; 106:1472–1477.doi.org/10.1016/j.rmed.2012.06.023
35. Mirsaeidi M, Farshidpour M, Allen MB, Ebrahimi G, Falkinham JO. Highlight on advances in nontuberculous mycobacterial disease in North America. BioMed Res Int. 2014; 2014:919474.doi.org/10.1155/2014/919474
36. Gopalaswamy R, Shanmugam S, Mondal R, Subbian S. Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment. J Biomed Sci. 2020; 27:74.doi.org/10.1186/s12929-020-00667-6
37. Park HK, Koh W-J, Shim TS, Kwon OJ. Clinical characteristics and treatment outcomes of Mycobacterium kansasii lung disease in Korea. Yonsei Med J. 2010; 51:552–556.doi.org/10.3349/ymj.2010.51.4.552
38. Anjos LRBD, Parreira PL, Torres PPTS, Kipnis A, Junqueira-Kipnis AP, Rabahi MF. Non-tuberculous mycobacterial lung disease: a brief review focusing on radiological findings. Rev Soc Bras Med Trop. 2020; 53:e20200241.doi.org/10.1590/0037-8682-0241-2020
39. Lee SH, Lee JH, Chang JH, et al. Hemoptysis requiring bronchial artery embolization in patients with nontuberculous mycobacterial lung disease. BMC Pulm Med. 2019; 19:117.doi.org/10.1186/s12890-019-0881-z
40. Ruhl CR, Pasko BL, Khan HS, et al. Mycobacterium tuberculosis Sulfolipid-1 Activates Nociceptive Neurons and Induces Cough. Cell. 2020; 181:293-305.e11.doi.org/10.1016/j.cell.2020.02.026
41. Kim K-B, Park S-G, Park J-S, et al. First Case of Pulmonary Mycobacterium parascrofulaceum Infection in a Patient With Bronchiectasis in Korea. Ann Lab Med. 2015; 35:379–381.doi.org/10.3343/alm.2015.35.3.379
42. Sinha KK, Singh PK, Singh U, Dixit P, Jain A. Occurrence and diversity of non-tuberculous mycobacteria among suspected and confirmed cases of pulmonary tuberculosis. J Acad Clin Microbiol. 2020; 22:12.doi.org/10.4103/jacm.jacm_13_19
43. Zemlyansky OA, Tyurina EB, Bashkirev AA, Kalyuzhnaya EV, Zemlyanskaya LO. Experience and Efficiency of Laboratory Diagnosis of Tuberculosis with PCR Detector System GeneXpert in Belgorod Region. Res J Pharm Technol. 2017; 10:743–746.doi.org/10.5958/0974-360X.2017.00139.1
44. Doya L, Dalloul D, Alkhayer M, Yazigi H. The importance of diagnosing Mycobacterium tuberculosis by real time PCR Compared with the approved diagnostic methods in the Clinical Laboratory. Res J Pharm Technol. 2018; 11:1513–1515.doi.org/10.5958/0974-360X.2018.00281.0